Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
500.1 INR | +1.57% | -9.47% | +38.77% |
05-10 | Solara Active Pharma to Raise 4.50 Billion Via Rights Issue | MT |
04-08 | Solara Active Pharma Sciences Limited Approves Appointment of Mohan Muthunarayanan as an Executive Director | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.77% | 212M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- SOLARA Stock
- News Solara Active Pharma Sciences Limited
- Transcript : Solara Active Pharma Sciences Limited, Q2 2024 Earnings Call, Nov 14, 2023